SYSTEM AND METHODS FOR ESTIMATING HBA1C, TREATMENT RESPONSE, AND HYPOGLYCEMIA RISK USING SELF-MONITORING OF BLOOD GLUCOSE DATA

• US 20120253840A1
• Filed: 10/25/2010
• Published: 10/04/2012
• Est. Priority Date: 12/21/2009
• Status: Abandoned Application

• Current Assignee: UNM Rainforest Innovations (f/k/a STC.UNM) (The University of New Mexico)
• Original Assignee: UNM Rainforest Innovations (f/k/a STC.UNM) (The University of New Mexico)
• Inventors: Murata, Glen H.
• Application Number:
  US13/505,103
• Publication Number:
  US 20120253840A1
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: G06Q 10/04 Forecasting or optimisation specially adapted for administrative or management purposes, e.g. linear programming or "cutting stock problem" market predictions or forecasting for commercial activities G06Q30/0202
• CPC Class Codes: G16H 10/40 for data related to laboratory analysis, e.g. patient specimen analysis
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 50/30 for calculating health indices; for individual health risk assessment

Abstract

A system and method for estimating HbA1c, diabetic patient treatment response and hypoglycemia risk using data obtained from patient self-monitoring of blood glucose. The system includes a computer having a processor, data storage, display, and data input ports. The data storage stores an insulin manager module that has instructions performed by the processor when self-monitoring of blood glucose (SMBD) data is provided to the computer via one of the data input ports. The processor uses the SMBD data to generate reports displaying estimated HbAIc and other factors effecting blood glucose levels in a diabetic patient and prescribes insulin treatment plans.

Claims

1. A system for evaluating SMBG data and selecting insulin treatment comprising:

a memory configured to store code;

a processor communicating with the memory storing code causing the processor to;

retrieve data comprising a plurality of blood glucose readings from the memory;

select a time period;

calculate a hemoglobin A1c (HbA1c) for the selected time period;

estimate adjustments to the calculated HbA1c for changes in the blood glucose readings;

calculate a contribution of each blood glucose reading from the retrieving to glycemic load; and

generate a treatment plan for regulating blood glucose in the patient.

2. The system for evaluating SMBG data and selecting insulin treatment of claim 1, wherein said processor further evaluates a possibility of the patient having a hypoglycemic event and generates a risk assessment score.

3. The system for evaluating SMBG data and selecting insulin treatment of claim 1, wherein said processor further identifies insulin targets having the greatest effect on glycemic control of the patient.

4. The system for evaluating SMBG data and selecting insulin treatment of claim 1, wherein the processor generates a treatment plan by selecting a type of insulin for the patient to inject.

5. The system for evaluating SMBG data and selecting insulin treatment of claim 1, wherein the processor generates a treatment plan by providing one or more patient insulin injection times.

6. The system for evaluating SMBG data and selecting insulin treatment of claim 1, wherein the contributions of each blood glucose reading are fractional contributions.

7. The system for evaluating SMBG data and selecting insulin treatment of claim 1, wherein the HbA1c is calculated from a 7-point blood glucose profile having blood glucose readings from seven different times of a day.

8. The system for evaluating SMBG data and selecting insulin treatment of claim 1, wherein the HbA1c is calculated from a 4-point blood glucose profile having blood glucose readings from four different times of a day.

9. The system for evaluating SMBG data and selecting insulin treatment of claim 1, wherein the HbA1c is calculated from a 2-point blood glucose profile having blood glucose readings from two different times of a day.

10. The system for evaluating SMBG data and selecting insulin treatment of claim 1, wherein the HbA1c is calculated from a single-point blood glucose profile having blood glucose readings from one time of a day.

11. The system for evaluating SMBG data and selecting insulin treatment of claim 1, wherein said processor calculates an area under a glucose concentration time curve to determine the HbA1c.

12. The system for evaluating SMBG data and selecting insulin treatment of claim 1, wherein said processor performs multiple linear modeling computations to calculate the HbA1c.

13. A method for providing advisories for the insulin dosage of a patient, comprising the steps of:

providing a plurality of blood glucose readings;

selecting a time period;

projecting a hemoglobin A1c (HbA1c) for the selected time period;

estimating adjustments to the calculated HbA1c for changes in the blood glucose readings;

calculating a contribution of each reading from said to excess glycemic load; and

providing treatment recommendations for regulating blood glucose in the patient.

14. The method for providing advisories on the insulin dosage of the patient according to claim 13, wherein said estimating step further includes a step of defining independent contributions of each blood glucose reading from said providing step to glycemic load.

15. The method for providing advisories on the insulin dosage of the patient according to claim 13, wherein said estimating step further includes a step of employing weighted values to account for different exposure times.

16. The method of claim 15, wherein the exposure times include pre-meal and bedtime blood glucose reading times.

17. The method for providing advisories on the insulin dosage of the patient according to claim 13, wherein said evaluating step further comprises the step of forecasting hypoglycemia by using pre-meal and bedtime blood glucose readings.

18. The method of claim 13, wherein said estimation step calculates the HbA1c by determining an area under a glucose concentration time curve.

19. The method of claim 13, wherein said estimation step calculates the HbA1c by performing multiple linear modeling computations.

20. The method of claim 13, wherein the blood glucose readings comprise one of a 7-point blood glucose profile and a 4-point blood glucose profile.